The bright colours of noble metal particles have attracted considerable interest since historical times, where they were used as decorative pigments in stained glass windows. More recently, the tuneable optical properties of metal nanoparticles and their addressability via spectroscopic techniques have brought them back into the forefront of fundamental and applied research fields. Much of the recent attention concerning metal nanoparticles such as gold and silver has been their use as small-volume, ultra-sensitive label-free optical sensors. Plasmonic nanoparticles act in this case as transducers that convert changes in the local refractive index into spectral shifts of the localized surface plasmon resonance (LSPR) band. This LSPR-shift assay is a general technique for measuring binding affinities and rates from any molecule that induces a change in the local refractive index around the metallic nanostructures. By attaching molecular recognition elements (chemical or biological ligands) on the nanostructures, specificity and selectivity to the analyte of interest are introduced into the nanosensor. In this review, we will discuss the different methods used to fabricate plasmonic nanosensors. A special emphasis will be given to techniques used to link plasmonic nanostructures to surfaces. While the difference between colorimetric and refractive index sensing approaches will be briefly described, the importance to distinguish between bulk refractive index (RI) sensing and molecular near-field refractive index sensing will be discussed. The recent progress made in the development of novel surface functionalization strategies together with the formation of optically and mechanically stable LSPR sensors will be highlighted.

Current efforts in the formulation of graphene-based nanocomposites with antimicrobial and antibiofilm activities in fighting against bacterial targets are reviewed.

Therapeutic options for the highly pathogenic human coronavirus (HCoV) infections are urgently needed. Anti-coronavirus therapy is however challenging, as coronaviruses are biologically diverse and rapidly mutating. In this work, the antiviral activity of seven different carbon quantum dots (CQDs) for the treatment of human coronavirus HCoV-229E infections was investigated. The first generation of antiviral CQDs was derived by hydrothermal carbonization from ethylenediamine/citric acid as carbon precursors and post-modified with boronic acid ligands. These nanostructures showed a concentration dependent virus inactivation with an estimated EC50 of 52±8 µg mL-1. CQDs derived from 4-aminophenylboronic acid without any further modification resulted in the second-generation of anti-HCoV nanomaterials with an EC50 lowered to 5.2±0.7 µg mL-1. The underlying mechanism of action of these CQDs revealed to be inhibition of HCoV-229E entry that could be due to interaction of the functional groups of the CQDs with HCoV-229E entry receptors; surprisingly, an equally large inhibition activity was observed at the viral replication step.